e-learning
resources
ERJ
2014
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Exhaled breath metabolomics as a noninvasive diagnostic tool for acute respiratory distress syndrome
Bos Lieuwe D.J., Weda Hans, Wang Yuanyue, Knobel Hugo H., Nijsen Tamara M.E., Vink Teunis J., Zwinderman Aeilko H., Sterk Peter J., Schultz Marcus J.
Source:
Eur Respir J 2014; 44: 188-197
Journal Issue:
July
Disease area:
Respiratory critical care
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Bos Lieuwe D.J., Weda Hans, Wang Yuanyue, Knobel Hugo H., Nijsen Tamara M.E., Vink Teunis J., Zwinderman Aeilko H., Sterk Peter J., Schultz Marcus J.. Exhaled breath metabolomics as a noninvasive diagnostic tool for acute respiratory distress syndrome. Eur Respir J 2014; 44: 188-197
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Indications and pitfalls of high-flow nasal cannula (HFNC) outside the intensive care unit
Inflammatory biomarkers are associated with aetiology and predict outcomes in community-acquired pneumonia: results of a 5-year follow-up cohort study
Related content which might interest you:
Exhaled breath analysis by use of eNose technology: a novel diagnostic tool for interstitial lung disease
Source: Eur Respir J, 57 (1) 2002042; 10.1183/13993003.02042-2020
Year: 2021
Exhaled breath CO and induced sputum in noninvasive assessment of COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 457s
Year: 2003
Metabolomic analysis of exhaled breath condensate in diagnostics of obstructive airway diseases
Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Year: 2011
Breath analysis for detection and trajectory monitoring of acute respiratory distress syndrome in swine
Source: ERJ Open Res, 8 (1) 00154-2021; 10.1183/23120541.00154-2021
Year: 2022
Exhaled breath condensate - a new tool for assessment of idiopathic pulmonary fibrosis?
Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia
Year: 2018
Detection of pepsin in sputum and exhaled breath condensate: could it be a useful marker for reflux-related respiratory disease?
Source: Annual Congress 2009 - What is new in the regulation and monitoring of airway function?
Year: 2009
Exhaled breath condensate biomarkers in COPD
Source: Eur Respir J 2008; 32: 472-486
Year: 2008
Prediction of asthma exacerbations in children by FeNO and non-invasive inflammatory markers in exhaled breath condensate
Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children
Year: 2008
Sensors for detecting pulmonary diseases from exhaled breath
Source: Eur Respir Rev, 28 (152) 190011; 10.1183/16000617.0011-2019
Year: 2019
Exhaled breath analysis using eNose technology in patients with sarcoidosis
Source: Virtual Congress 2020 – Sarcoidosis: from genetics to epidemiology
Year: 2020
Prediction of CF exacerbations by FeNO and non-invasive inflammatory markers in exhaled breath condensate
Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation
Year: 2008
Is the analysis of torbamycin in exhaled breath condensate a diagnostic tool to monitor pulmonary drug deposition?
Source: Eur Respir J 2004; 24: Suppl. 48, 386s
Year: 2004
Assessment of exhaled breath condensate for non-invasive diagnosis of gastroesophageal reflux disease
Source: International Congress 2017 – Chronic airway disease: markers of disease impact
Year: 2017
Identifying biomarkers of loss of control/exacerbations in asthma from exhaled breath
Source: ERS Lung Science Conference 2016
Year: 2016
Overview of current lung imaging in acute respiratory distress syndrome
Source: Eur Respir Rev 2014; 23: 519-530
Year: 2014
Exhaled breath: Non-invasive diagnosis of ventilator-associated pneumonia
Source: International Congress 2015 – Prognostic factors in pneumonia: from clinical observations to experimental models
Year: 2015
Laryngeal ultrasound as a bedside tool in detecting post-extubation stridor in patients with respiratory illness
Source: International Congress 2017 – New insights into acute critical care
Year: 2017
Differential diagnosis between newly diagnosed asthma and COPD using exhaled breath condensate metabolomics: a pilot study
Source: Eur Respir J, 51 (3) 1701825; 10.1183/13993003.01825-2017
Year: 2018
Exhaled breath temperature in children with chronic cough
Source: International Congress 2019 – New insights into childhood infections: from viral bronchiolitis to bronchiolitis obliterans
Year: 2019
More awareness is needed for severe acute respiratory syndrome coronavirus 2019 transmission through exhaled air during non-invasive respiratory support: experience from China
Source: Eur Respir J, 55 (3) 2000352; 10.1183/13993003.00352-2020
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept